Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,338 | -3,009 | -3,795 |
| Depreciation Amortization | 463 | 506 | 219 |
| Other Working Capital | 535 | 277 | 17 |
| Other Operating Activity | 50 | 57 | 49 |
| Operating Cash Flow | $-3,289 | $-2,169 | $-3,510 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -282 | -214 | -1,144 |
| Other Investing Activity | -2,113 | 30 | -140 |
| Investing Cash Flow | $-2,395 | $-184 | $-1,285 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 3,539 | -229 | 11,572 |
| Financing Cash Flow | $3,539 | $-229 | $11,572 |
| Beginning Cash Position | 5,711 | 8,293 | 1,516 |
| End Cash Position | 3,565 | 5,711 | 8,293 |
| Net Cash Flow | $-2,146 | $-2,582 | $6,777 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,289 | -2,169 | -3,510 |
| Free Cash Flow | -3,289 | -2,169 | -3,510 |